Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)

Surgery (United States)

Volumn 155, Issue 6, 2014, Pages 977-988

  Bockhorn, Maximilian ^a   Uzunoglu, Faik G ^a   Adham, Mustapha ^b   Imrie, Clem ^c   Milicevic, Miroslav ^d   Sandberg, Aken A ^e   Asbun, Horacio J ^f   Bassi, Claudio ^g   Büchler, Markus ^h   Charnley, Richard M ⁱ   Conlon, Kevin ^j   Cruz, Laureano Fernandez ^k   Dervenis, Christos ^l   Fingerhutt, Abe ^m   Friess, Helmut ⁿ   Gouma, Dirk J ^o   Hartwig, Werner ^h   Lillemoe, Keith D ^p   Montorsi, Marco ^q   Neoptolemos, John P ^r   Shrikhande, Shailesh V ^s   Takaori, Kyoichi ^t   Traverso, William ^u   Vashist, Yogesh K ^a   Vollmer, Charles ^v   Yeo, Charles J ^w   Izbicki, Jakob R ^a   more..

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF BELGRADE   (Serbia)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF VERONA   (Italy)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ FREEMAN HOSPITAL   (United Kingdom)

^j TRINITY COLLEGE DUBLIN   (Ireland)

^k UNIVERSITY OF BARCELONA   (Spain)

^l AGIA OLGA HOSPITAL   (Greece)

^m CENTRE HOSPITALIER INTERCOMMUNAL   (France)

ⁿ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^o UNIVERSITY OF AMSTERDAM   (Netherlands)

^p MASSACHUSETTS GENERAL HOSPITAL   (United States)

^q UNIVERSITY OF MILAN   (Italy)

^r UNIVERSITY OF LIVERPOOL   (United Kingdom)

^s TATA MEMORIAL HOSPITAL   (India)

^t KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^u St Luke's Clinic Center for Pancreatic and Liver Diseases   (United States)

^v HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^w THOMAS JEFFERSON UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; CA 19-9 ANTIGEN;

ADVENTITIA; ARTICLE; BORDERLINE RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONSENSUS; DISTANT METASTASIS; HUMAN; LONG TERM SURVIVAL; MEDICAL SOCIETY; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS SURGERY; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SUPERIOR MESENTERIC ARTERY; SUPERIOR MESENTERIC VEIN; SURGICAL MORTALITY; SURVIVAL PREDICTION; TUMOR INVASION;

CARCINOMA, PANCREATIC DUCTAL; HUMANS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PATIENT SELECTION; PREOPERATIVE CARE; PROGNOSIS;

EID: 84901455120     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2014.02.001     Document Type: Article

References (74)

1. World Health Organization: Regional Office for Europe The European health report 2012: charting the way to well-being 2012 WHO Geneva
2. National Cancer Insitute. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Available from: http://seer.cancer.gov/csr/1975- 2009-pops09/.
3. S. Asada, H. Itaya, K. Nakamura, T. Isohashi, and S. Masuoka Radical pancreatoduodenectomy and portal vein resection. Report of two successful cases with transplantation of portal vein Arch Surg 87 1963 609 613
4. J.G. Fortner Regional resection of cancer of the pancreas: a new surgical approach Surgery 73 1973 307 320
5. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti AJCC cancer staging manual 7th ed. 2010 Springer-Verlag New York
6. J. Andrews, G. Guyatt, A.D. Oxman, P. Alderson, P. Dahm, and Y. Falck-Ytter et al. GRADE guidelines: 14. going from evidence to recommendations: the significance and presentation of recommendations J Clin Epidemiol 66 2013 719 725
7. D.S. Lu, S. Vedantham, R.M. Krasny, B. Kadell, W.L. Berger, and H.A. Reber Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures Radiology 199 1996 697 701
8. J.G. Fletcher, M.J. Wiersema, M.A. Farrell, J.L. Fidler, L.J. Burgart, and T. Koyama et al. Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT Radiology 229 2003 81 90
9. J.C. Wong, and D.S. Lu Staging of pancreatic adenocarcinoma by imaging studies Clin Gastroenterol Hepatol 6 2008 1301 1308
10. B.L. Appel, P. Tolat, D.B. Evans, and S. Tsai Current staging systems for pancreatic cancer Cancer J 18 2012 539 549
11. G.R. Varadhachary, E.P. Tamm, J.L. Abbruzzese, H.Q. Xiong, C.H. Crane, and H. Wang et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy Ann Surg Oncol 13 2006 1035 1046
12. R.A. Abrams, A.M. Lowy, E.M. O'Reilly, R.A. Wolff, V.J. Picozzi, and P.W. Pisters Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement Ann Surg Oncol 16 2009 1751 1756
13. M.P. Callery, K.J. Chang, E.K. Fishman, M.S. Talamonti, L. William Traverso, and D.C. Linehan Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement Ann Surg Oncol 16 2009 1727 1733
14. D.B. Evans, M.B. Farnell, K.D. Lillemoe, C. Vollmer Jr., S.M. Strasberg, and R.D. Schulick Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement Ann Surg Oncol 16 2009 1736 1744
15. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Pancreatic Adenocarcinoma. Version 2.2012 ed 2012. Available from: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp.
16. H.P. Siriwardana, and A.K. Siriwardena Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer Br J Surg 93 2006 662 673
17. M. Adham, D.F. Mirza, F. Chapuis, A.D. Mayer, S.R. Bramhall, and C. Coldham et al. Results of vascular resections during pancreatectomy from two European centres: an analysis of survival and disease-free survival explicative factors HPB (Oxford) 8 2006 465 473
18. J.F. Tseng, C.P. Raut, J.E. Lee, P.W. Pisters, J.N. Vauthey, and E.K. Abdalla et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration J Gastrointest Surg 8 2004 935 949 discussion 949-50
19. G.M. Fuhrman, S.D. Leach, C.A. Staley, J.C. Cusack, C. Charnsangavej, and K.R. Cleary et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group Ann Surg 223 1996 154 162
20. T. Nakagohri, T. Kinoshita, M. Konishi, K. Inoue, and S. Takahashi Survival benefits of portal vein resection for pancreatic cancer Am J Surg 186 2003 149 153
21. L.E. Harrison, D.S. Klimstra, and M.F. Brennan Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection? Ann Surg 224 1996 342 347 discussion 347-9
22. Y. Zhou, Z. Zhang, Y. Liu, B. Li, and D. Xu Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis World J Surg 36 2012 884 891
23. E.F. Yekebas, D. Bogoevski, G. Cataldegirmen, C. Kunze, A. Marx, and Y.K. Vashist et al. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients Ann Surg 247 2008 300 309
24. G. Illuminati, F. Carboni, R. Lorusso, A. D'Urso, G. Ceccanei, and V. Papaspyropoulos et al. Results of a pancreatectomy with a limited venous resection for pancreatic cancer Surgery Today 38 2008 517 523
25. S. Fukuda, E. Oussoultzoglou, P. Bachellier, E. Rosso, H. Nakano, and M. Audet et al. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma Arch Surg 142 2007 172 179 discussion 180
26. G. Ramacciato, P. Mercantini, N. Petrucciani, V. Giaccaglia, G. Nigri, and M. Ravaioli et al. Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? Ann Surg Oncol 16 2009 817 825
27. M. Glanemann, B. Shi, F. Liang, X.G. Sun, M. Bahra, and D. Jacob et al. Surgical strategies for treatment of malignant pancreatic tumors: extended, standard or local surgery? World J Surg Oncol 6 2008 123
28. K.J. Kelly, E. Winslow, D. Kooby, N.L. Lad, A.A. Parikh, and C.R. Scoggins et al. Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of borderline resectable disease? J Gastrointest Surg 17 2013 1209 1217
29. M. Ouaissi, C. Hubert, R. Verhelst, P. Astarci, C. Sempoux, and A. Jouret-Mourin et al. Vascular reconstruction during pancreatoduodenectomy for ductal adenocarcinoma of the pancreas improves resectability but does not achieve cure World J Surg 34 2010 2648 2661
30. S.A. Muller, M. Hartel, A. Mehrabi, T. Welsch, D.J. Martin, and U. Hinz et al. Vascular resection in pancreatic cancer surgery: survival determinants J Gastrointest Surg 13 2009 784 792
31. M. Worni, A.W. Castleberry, B.M. Clary, B. Gloor, E. Carvalho, and D.O. Jacobs et al. Concomitant vascular reconstruction during pancreatectomy for malignant disease: a propensity score-adjusted, population-based trend analysis involving 10 206 patients Arch Surg 2012 1 8
32. N. Mollberg, N.N. Rahbari, M. Koch, W. Hartwig, Y. Hoeger, and M.W. Buchler et al. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis Ann Surg 254 2011 882 893
33. M. Bockhorn, C. Burdelski, D. Bogoevski, G. Sgourakis, E.F. Yekebas, and J.R. Izbicki Arterial en bloc resection for pancreatic carcinoma Br J Surg 98 2011 86 92
34. W. Hartwig, T. Hackert, U. Hinz, M. Hassenpflug, O. Strobel, and M.W. Buchler et al. Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome Ann Surg 250 2009 81 87
35. P. Bachellier, E. Rosso, I. Lucescu, E. Oussoultzoglou, J. Tracey, and P. Pessaux et al. Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study J Surg Oncol 103 2011 75 84
36. S. Kondo, H. Katoh, T. Shimizu, M. Omi, S. Hirano, and Y. Ambo et al. Preoperative embolization of the common hepatic artery in preparation for radical pancreatectomy for pancreas body cancer Hepatogastroenterology 47 2000 1447 1449
37. K. Okada, M. Kawai, M. Tani, S. Hirono, M. Miyazawa, and A. Shimizu et al. Surgical strategy for patients with pancreatic body/tail carcinoma: who should undergo distal pancreatectomy with en-bloc celiac axis resection? Surgery 153 2013 365 372
38. S. Hirano, S. Kondo, T. Hara, Y. Ambo, E. Tanaka, and T. Shichinohe et al. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results Ann Surg 246 2007 46 51
39. Y. Nakayama, Y. Yamashita, M. Kadota, M. Takahashi, K. Kanemitsu, and T. Hiraoka et al. Vascular encasement by pancreatic cancer: correlation of CT findings with surgical and pathologic results J Comput Assist Tomogr 25 2001 337 342
40. H. Li, M.S. Zeng, K.R. Zhou, D.Y. Jin, and W.H. Lou Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion J Comput Assist Tomogr 29 2005 170 175
41. J.F. Pingpank, J.P. Hoffman, E.A. Ross, H.S. Cooper, N.J. Meropol, and G. Freedman et al. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas J Gastrointest Surg 5 2001 121 130
42. J.M. Laurence, P.D. Tran, K. Morarji, G.D. Eslick, V.W. Lam, and C. Sandroussi A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer J Gastrointest Surg 15 2011 2059 2069
43. M.H. Katz, J.B. Fleming, P. Bhosale, G. Varadhachary, J.E. Lee, and R. Wolff et al. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators Cancer 118 2012 5749 5756
44. K.T. Papalezova, D.S. Tyler, D.G. Blazer III, B.M. Clary, B.G. Czito, and H.I. Hurwitz et al. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer? J Surg Oncol 106 2012 111 118
45. D.A. Tuveson, and J.P. Neoptolemos Understanding metastasis in pancreatic cancer: a call for new clinical approaches Cell 148 2012 21 23
46. A.D. Rhim, E.T. Mirek, N.M. Aiello, A. Maitra, J.M. Bailey, and F. McAllister et al. EMT and dissemination precede pancreatic tumor formation Cell 148 2012 349 361
47. M.H. Katz, S. Ahmad, and H. Nelson Borderline resectable pancreatic cancer: pushing the technical limits of surgery Bull Am Coll Surg 98 2013 61 63
48. G. Butturini, D.D. Stocken, M.N. Wente, H. Jeekel, J.H. Klinkenbijl, and K.E. Bakkevold et al. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials Arch Surg 143 2008 75 83 discussion 83
49. C.S. Verbeke, and K.V. Menon Redefining resection margin status in pancreatic cancer HPB (Oxford) 11 2009 282 289
50. K.Y. Bilimoria, M.S. Talamonti, S.F. Sener, M.M. Bilimoria, A.K. Stewart, and D.P. Winchester et al. Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer J Am Coll Surg 207 2008 510 519
51. The Royal College of Pathologists Standards and datasets for reporting cancers. Minimum dataset for the histopathological reporting of pancreatic, ampulla of vater and bile duct carcinoma 2002 The Royal College of Pathologists London, UK
52. K.V. Menon, D. Gomez, A.M. Smith, A. Anthoney, and C.S. Verbeke Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP) HPB (Oxford) 11 2009 18 24
53. L.H. Sobin, M.K. Gospodarowicz, C. Wittekind International Union against Cancer TNM classification of malignant tumours 7th ed. 2010 Wiley-Blackwell Chichester, West Sussex, UK; Hoboken, NJ
54. C. Wittekind, C. Compton, P. Quirke, I. Nagtegaal, S. Merkel, and P. Hermanek et al. A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status Cancer 115 2009 3483 3488
55. I. Esposito, J. Kleeff, F. Bergmann, C. Reiser, E. Herpel, and H. Friess et al. Most pancreatic cancer resections are R1 resections Ann Surg Oncol 15 2008 1651 1660
56. C.S. Verbeke, D. Leitch, K.V. Menon, M.J. McMahon, P.J. Guillou, and A. Anthoney Redefining the R1 resection in pancreatic cancer Br J Surg 93 2006 1232 1237
57. N.B. Jamieson, S.M. Denley, J. Logue, D.J. MacKenzie, A.K. Foulis, and E.J. Dickson et al. A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma Ann Surg Oncol 18 2011 2318 2328
58. N.B. Jamieson, A.K. Foulis, K.A. Oien, J.J. Going, P. Glen, and E.J. Dickson et al. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma Ann Surg 251 2010 1003 1010
59. W. Hartwig, T. Hackert, U. Hinz, A. Gluth, F. Bergmann, and O. Strobel et al. Pancreatic cancer surgery in the new millennium: better prediction of outcome Ann Surg 254 2011 311 319
60. J.P. Neoptolemos, D.D. Stocken, J.A. Dunn, J. Almond, H.G. Beger, and P. Pederzoli et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial Ann Surg 234 2001 758 768
61. D.K. Chang, A.L. Johns, N.D. Merrett, A.J. Gill, E.K. Colvin, and C.J. Scarlett et al. Margin clearance and outcome in resected pancreatic cancer J Clin Oncol 27 2009 2855 2862
62. N.B. Jamieson, N.I. Chan, A.K. Foulis, E.J. Dickson, C.J. McKay, and C.R. Carter The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma J Gastrointest Surg 17 2013 511 521
63. C.P. Raut, J.F. Tseng, C.C. Sun, H. Wang, R.A. Wolff, and C.H. Crane et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Ann Surg 246 2007 52 60
64. C. Shibata, M. Kobari, T. Tsuchiya, K. Arai, R. Anzai, and M. Takahashi et al. Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcinoma in pancreas World J Surg 25 2001 1002 1005
65. S.S. Han, S.J. Park, S.H. Kim, S.Y. Cho, Y.K. Kim, and T.H. Kim et al. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer Pancreas 41 2012 102 106
66. M.H. Katz, P.W. Pisters, D.B. Evans, C.C. Sun, J.E. Lee, and J.B. Fleming et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease J Am Coll Surg 206 2008 833 846 discussion 846-8
67. M. La Torre, G. Nigri, M. Cavallini, P. Mercantini, V. Ziparo, and G. Ramacciato The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma Ann Surg Oncol 19 2012 2917 2923
68. D.C. McMillan The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer Cancer Treatment Rev 39 2013 534 540
69. D.S. Wang, H.Y. Luo, M.Z. Qiu, Z.Q. Wang, D.S. Zhang, and F.H. Wang et al. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer Med Oncol 29 2012 3092 3100
70. M. Stotz, A. Gerger, F. Eisner, J. Szkandera, H. Loibner, and A.L. Ress et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer Br J Cancer 109 2013 416 421
71. W. Hartwig, O. Strobel, U. Hinz, S. Fritz, T. Hackert, and C. Roth et al. CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy Ann Surg Onocl 20 2013 2188 2196
72. K.M. Reid-Lombardo, B.L. Fridley, W.R. Bamlet, J.M. Cunningham, M.G. Sarr, and G.M. Petersen Survival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer Ann Surg 257 2013 1096 1102
73. F.G. Uzunoglu, J. Kolbe, H. Wikman, C. Gungor, B.A. Bohn, and M.F. Nentwich et al. VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma Ann Oncol 24 2013 1282 1290
74. G.R. Varadhachary Preoperative therapies for resectable and borderline resectable pancreatic cancer J gastrointest Oncol 2 2011 136 142